Medicare Enrolled

Dr. Nasrin Ghesani, MD

Nuclear Medicine · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1 GUSTAVE L LEVY PL # 1141, New York, NY 10029
2122416611
In practice since 2006 (19 years)
NPI: 1023193000 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ghesani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ghesani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ghesani

Dr. Nasrin Ghesani is a nuclear medicine specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ghesani performed 2,764 Medicare services across 796 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ghesani received a total of $8,944 from 6 pharmaceutical and/or device companies across 19 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ghesani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 15% volume in NY $8,944 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,764
Medicare services
Top 15% in NY for nuclear medicine
796
Unique beneficiaries
$252
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~145 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
1,022 $0 $1
Gallium Ga-68 dotatate diagnostic injection
A diagnostic injection of Gallium Ga-68 dotatate used for imaging. The dose specified is 0.1 millicurie.
648 $44 $56
Piflufolastat F-18 diagnostic injection
A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie.
306 $471 $600
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
268 $1,162 $4,120
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 236 $227 $304
Whole body nuclear medicine scan with CT
A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body.
95 $1,377 $5,072
SPECT/CT scan, single area
A nuclear medicine imaging study that combines single-photon emission computed tomography (SPECT) with a concurrent CT scan to create detailed images of a single body area.
21 $428 $4,050
Radioactive drug therapy through a vein
Administration of a radioactive medication directly into the bloodstream via an intravenous line.
21 $80 $410
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
19 $114 $717
Technetium Tc-99m medronate diagnostic injection
An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study.
19 $17 $21
Whole body bone and joint nuclear medicine scan
A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body.
18 $264 $925
Technetium Tc-99m sulfur colloid diagnostic injection
A diagnostic injection of Technetium Tc-99m sulfur colloid used for imaging studies. The dose administered is up to 20 millicuries per study.
18 $82 $103
Whole body nuclear medicine scan
A diagnostic imaging test that uses a small amount of radioactive material to create pictures of the entire body. It helps doctors evaluate the structure and function of organs and tissues throughout the body.
17 $33 $575
Radioactive drug therapy via arterial tube
Administration of a radioactive therapeutic agent through a catheter inserted into an artery to target specific tissues.
17 $99 $529
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
15 $273 $1,173
Nuclear stress test with CT scan
A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan.
12 $78 $254
PET scan of heart muscle blood flow
A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle.
12 $26 $92
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,944
Total received (2020-2024)
Avg $1,789/year across 5 years
Top 12% in NY for nuclear medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
6
Companies
19
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,182 (57.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,762 (42.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,772
2023
$3,130
2022
$165
2021
$22
2020
$3,855

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Telix Pharmaceuticals
$1,543
Blue Earth Diagnostics Limited
$123
PFIZER INC.
$107
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2020-2024) ›
Telix Pharmaceuticals
$4,673
Eisai Inc.
$3,762
Blue Earth Diagnostics Limited
$287
PFIZER INC.
$107
Advanced Accelerator Applications
$93
GE HEALTHCARE
$22
Top 3 companies account for 97.5% of all-time payments
Associated products mentioned in payments ›
Axumin · ILLUCCIX · LUTATHERA · POSLUMA · TALZENNA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nuclear medicine specialist in New York?
Compare nuclear medicines in the New York area by procedure volume, costs, and industry payment transparency.
Browse nuclear medicines nearby

Geographic Context

Nuclear medicines within 10 mi
93
Per 100K population
5.7
County median income
$104,553
Nearest hospital
MOUNT SINAI HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ghesani is a mixed practice specialist, with above-average Medicare volume (top 15% in NY), with low-engagement industry engagement in the top 12% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ghesani experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Ghesani performed 1,022 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ghesani receive payments from pharmaceutical companies?
Yes. Dr. Ghesani received a total of $8,944 from 6 companies across 19 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ghesani's costs compare to other nuclear medicines in New York?
Dr. Ghesani's average Medicare payment per service is $252. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ghesani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →